FDA Panel Gives Support to Merck’s COVID Antiviral Pill
TUESDAY, Nov. 30, 2021 (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend emergency use of Merck’s new antiviral pill to help prevent severe COVID-19 in high-risk patients. By a 13-10 count, the panelists recommended molnupiravir for use by older COVID-19 patientsContinue Reading